Related Experiment Video

Updated: Jul 18, 2026

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture
09:06

Manipulation of Epileptiform Electrocorticograms (ECoGs) and Sleep in Rats and Mice by Acupuncture

Published on: December 22, 2016

Valproate and delta-sleep peptide display high efficacy against metaphit-induced audiogenic seizure in rats

O Stanojlović1, D Hrncić, D Zivanović

  • 1Department of Physiology, School of Medicine, University of Belgrade, Visegradska 26/II, 11000 Belgrade, Serbia maxol@eunet.yu

Acta Physiologica Hungarica
|December 29, 2006
PubMed

Insights

Valproate (VPA) and delta sleep-inducing peptide (DSIP) both reduced metaphit-induced seizures in rats. VPA acted quickly, while DSIP provided a longer-lasting, milder effect.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Generalized seizures can be induced by metaphit, a chemical convulsant.
  • Valproate (VPA) and delta sleep-inducing peptide (DSIP) are known for their modulatory effects on neuronal activity.

Purpose of the Study:

  • To compare the efficacy of VPA and DSIP in mitigating metaphit-induced seizures in male rats.
  • To investigate the dose-dependent effects and onset/duration of action for both VPA and DSIP.

Main Methods:

  • Adult male rats were administered metaphit to induce seizures.
  • VPA or DSIP were administered at various doses 8 hours post-metaphit.
  • EEG and behavioral analysis were conducted following sound stimulation to assess seizure activity.

Main Results:

  • Both VPA and DSIP dose-dependently reduced seizure incidence and increased latency.
  • VPA demonstrated a rapid onset of action, while DSIP exhibited a prolonged, milder effect.
  • Neither VPA nor DSIP completely abolished metaphit-induced epileptiform EEG activity.

Conclusions:

  • VPA and DSIP show anticonvulsant properties against metaphit-induced seizures.
  • The distinct pharmacokinetic profiles of VPA and DSIP influence their therapeutic potential.
  • Further research may explore combination therapies or optimized dosing for enhanced seizure control.

More Related Videos

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats08:47

Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats

Published on: November 8, 2018

Related Concept Videos

Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...